Circular CRISPR Edits Human Pluripotent Stem Cells for Disease Modeling
Stem Cell Reviews and Reports · 2025
DOI: 10.1007/s12015-025-10871-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stem Cell Reviews and Reports, 2025. Verfasst von Weihao Bao und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Cardiovascular Disease, Key Laboratory of Pluripotent Stem Cells in Cardiac Repair and Regeneration, Fuwai Hospital, National…. Hauptthemen laut MEDLINE: Gene Editing, Pluripotent Stem Cells, CRISPR-Cas Systems, RNA, Circular. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation, Shenzhen Medical Research Fund.
Abstract (Originalsprache)
The CRISPR system has been widely used for human pluripotent stem cell (hPSC) disease modeling. Circular RNA can effectively reduce RNA immunogenicity and improve RNA stability, thus contributing to in vivo DNA editing. In this study, we briefly describe the process of circularizing guide RNA and CRISPR base editing elements and using them to establish stem cell disease models. Our work provides step-by-step guidance for constructing gene point editing cell lines, offering a reliable, low-immunogenic alternative for disease modeling and therapeutic research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Cardiovascular Disease, Key Laboratory of Pluripotent Stem Cells in Cardiac Repair and Regeneration, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Scienc…
- Department of Cardiovascular Surgery, Metabolic Vascular Diseases Key Laboratory of Sichuan Province, Key Laboratory of Cardiovascular Remodeling and Dysfunction, The Affiliated Hospital, Southwest Medical University, L…
- Shenzhen Key Laboratory of Cardiovascular Disease, Fuwai Hospital Chinese Academy of Medical Sciences, Shenzhen, Shenzhen, 518057, China. fenglan@ccmu.edu.cn.
- Shenzhen Key Laboratory of Cardiovascular Disease, Fuwai Hospital Chinese Academy of Medical Sciences, Shenzhen, Shenzhen, 518057, China. mashuhong@fuwai.com.
ORCID-Profile: Shuhong Ma
Förderung
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Shenzhen Medical Research Fund
Zitieren
APA
Bao, W., Fan, W., Zhang, Y., Lan, F., & Ma, S. (2025). Circular CRISPR Edits Human Pluripotent Stem Cells for Disease Modeling. Stem Cell Reviews and Reports. https://doi.org/10.1007/s12015-025-10871-2
Vancouver
Bao W, Fan W, Zhang Y, Lan F, Ma S. Circular CRISPR Edits Human Pluripotent Stem Cells for Disease Modeling. Stem Cell Reviews and Reports. 2025. doi:10.1007/s12015-025-10871-2
BibTeX
@article{Bao2025,
author = {Bao, Weihao and Fan, Wei and Zhang, Yongshuai and Lan, Feng and Ma, Shuhong},
title = {Circular CRISPR Edits Human Pluripotent Stem Cells for Disease Modeling},
journal = {Stem Cell Reviews and Reports},
year = {2025},
doi = {10.1007/s12015-025-10871-2}
}
EUVIMED